Company Information

CIN
Status
Date of Incorporation
24 September 1993
State / ROC
Ahmedabad / ROC Ahmedabad
Last Balance Sheet
31 March 2023
Last Annual Meeting
29 September 2023
Paid Up Capital
42,900,000
Authorised Capital
50,000,000

Directors

Tejash Vijay Shah
Tejash Vijay Shah
Director/Designated Partner
about 2 years ago
Raheel Shah
Raheel Shah
Director/Designated Partner
about 2 years ago
Trushit Mehta
Trushit Mehta
Director/Designated Partner
over 2 years ago
Binita Dharmesh Shah
Binita Dharmesh Shah
Beneficial Owner
over 6 years ago
Dheer Dharmesh Shah
Dheer Dharmesh Shah
Director/Designated Partner
over 7 years ago
Sanjay Amritlal Solanki
Sanjay Amritlal Solanki
Director/Designated Partner
almost 16 years ago
Amol Jashwant Shah
Amol Jashwant Shah
Director
about 25 years ago

Past Directors

Chandrashekhar Jagdishchandra Lohani
Chandrashekhar Jagdishchandra Lohani
Additional Director
over 4 years ago
Ketan Suresh Shah
Ketan Suresh Shah
Additional Director
over 15 years ago
Guruprasad Ramchandra Vader
Guruprasad Ramchandra Vader
Director
about 17 years ago
Dharmesh Mahendra Shah
Dharmesh Mahendra Shah
Director
over 20 years ago

Patents

“An Improved Process For The Preparation Of Lenvatinib”

The present invention relates to an improved and economic industrial process for the preparation of Lenvatinib and salt thereof. The present invention also relates to method and novel use of a reagent for preparing an amorphous form of Lenvatinib mesylate (V) monohydrate.

“Eco Friendly Process For The Prepration Of High Purity Sunitinib And Pharmaceutically Acceptable Salt Thereof”

ECO-FRIENDLY PROCESS FOR THE PREPRATION OF HIGH PURITY SUNITINIB AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF The present invention relates to an improved, economical and eco-friendly large-scale industrial process for the preparation of Sunitinib and pharmaceutically acceptable salt thereof. The main advantage of ...

Novel Processes For The Preparation Of Rucaparib

The present invention relates to novel, improved and economic industrial processes for the preparation of Rucaparib of formula-I. The present invention also discloses use of novel intermediates to synthesize Rucaparib with high yield and purity. Further, the present invention produces Rucaparib with high yield and i...

Novel Intermediates And Process For Preparation Of Axitinib

NOVEL INTERMEDIATES AND PROCESS FOR PREPARATION OF AXITINIB The present invention relates to an improved, economical and large-scale industrial process for the preparation of Axitinib (formula I) and pharmaceutically acceptable salt thereof. The present invention involves use of a novel intermediates for the prepar...

An Improved Highly Efficient Process For The Prepration Of Nintedanib And Pharmaceutically Acceptable Salt Thereof

AN IMPROVED HIGHLY EFFICIENT PROCESS FOR THE PREPRATION OF NINTEDANIB AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF The present invention relates to an improved highly efficient and economic process for large-scale production of Nintedanib and pharmaceutically acceptable salt thereof. The present invention also re...

An Improved Process For The Preparation Of Pomalidomide

ABSTRACT AN IMPROVED PROCESS FOR THE PREPARATION OF POMALIDOMIDE The present invention relates to an improved and economic industrial process for the preparation of pomalidomide. The present invention also relates to method and novel use of a reagent for preparing Pomalidomide.

An Improved Process For The Preparation Of Lenvatinib

ABSTRACT “AN IMPROVED PROCESS FOR THE PREPARATION OF LENVATINIB” The present invention relates to an improved and economic industrial process for the preparation of amorphous form of Lenvatinib mesylate with reduced processing steps, high yield and stability. The present invention also relates to process for t...

A Novel Process For The Preparation Of Ruxolitinib Phosphate

ABSTRACT A NOVEL PROCESS FOR THE PREPARATION OF RUXOLITINIB PHOSPHATE The present invention relates to a novel and economic industrial process for the preparation of Ruxolitinib phosphate with high yield, reduced steps and high stability. The present invention also relates to process for the preparation of Rux...

“An Improved Process For The Preparation Of Molnupiravir”

“AN IMPROVED PROCESS FOR THE PREPARATION OF MOLNUPIRAVIR” The present invention provides an improved, environment-friendly and large-scale industrial process for the preparation of Molnupiravir and purification thereof. The present invention also avoids use of hazardous reagents and provides environment-friendly pr...

“Process For Removal Of Degradation Impurity N Formyl Azacitidine From Azacitidine”

The present invention provides an improved and large-scale industrial process for removal of degradation impurity N-formyl Azacitidine from Azacitidine. The present invention also avoids use of water and provides an economical and technically facile process for removal of degradation impurity from Azacitidine. The m...

“An Efficient Process For The Prepration Of Palbociclib Intermediate With Improved Yield”

“AN EFFICIENT PROCESS FOR THE PREPRATION OF PALBOCICLIB INTERMEDIATE WITH IMPROVED YIELD” The present invention provides an efficient and large-scale industrial process for the preparation of Palbociclib Intermediate. The present invention also provides technically simple process for the preparation of Palbociclib ...

Novel Process And Intermediate For The Preparation Of Apalutamide

The present invention relates to novel highly efficient and economic process for large-scale production of Apalutamide. The present invention also relates to novel process that form highly pure Apalutamide through a novel intermediate. This process avoids use of expensive and hazardous reagents and solvents. Along w...

A Process For The Preparation Of Relugolix

ABSTRACT “A PROCESS FOR THE PREPARATION OF RELUGOLIX” The present invention relates an improved process for the preparation relugolix of formula I, pharmaceutically acceptable salts thereof. Over and above that, the present invention relates to providing an economical and technically facile process for the pre...

Charges

0
03 March 1999
Idbi Bank Ltd.
8 Crore
03 March 1999
Idbi Bank Ltd.
0
03 March 1999
Idbi Bank Ltd.
0

Documents

Form AOC-4(XBRL)-05012021_signed
Form MGT-7-04012021_signed
Copy of MGT-8-29122020
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-29122020
Optional Attachment-(1)-29122020
List of share holders, debenture holders;-29122020
Form MSME FORM I-29102020_signed
Form DPT-3-30092020-signed
Auditor?s certificate-19092020
Form DPT-3-06012020-signed
Form DPT-3-09122019-signed
Form MGT-7-17112019_signed
Form MSME FORM I-11112019_signed
Form AOC-4(XBRL)-23102019_signed
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-21102019
Copy of MGT-8-19102019
List of share holders, debenture holders;-19102019
Form BEN - 2-26082019_signed
Declaration under section 90-26082019
Form MSME FORM I-08062019_signed
Form MSME FORM I-21052019_signed
List of share holders, debenture holders;-04102018
Copy of MGT-8-04102018
Optional Attachment-(1)-04102018
Form MGT-7-04102018_signed
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-01102018
Company CSR policy as per section 135(4)-01102018
Directors report as per section 134(3)-01102018
Optional Attachment-(1)-01102018
Form DIR-12-01102018_signed